Evidence map›Paper›PMID 8665475›Full record

ReviewClinical microbiology reviews1996

Activation of the complement system by pathogenic fungi.

T R Kozel

Open access · greenAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 144 citations in OpenAlex.

  1. Phagosome maturation during fungal infection.Current opinion in microbiology · 2026
    Review
  2. Article
  3. Review
  4. Diverse Functions of C4b-Binding Protein in Health and Disease.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  5. Article
  6. Biological and Clinical Attributes ofInfection and drug resistance · 2022
    Review
  7. Protective role of host complement system inFrontiers in immunology · 2022
    Article
  8. Article
  9. The amphibian complement system and chytridiomycosis.Journal of experimental zoology. Part A, Ecological and integrative physiology · 2020
    Review
  10. Frontiers in immunology · 2020
    Review
  11. Mechanisms of PathogenicFrontiers in cellular and infection microbiology · 2020
    Review
  12. Review
  13. Article
  14. Immunity to Commensal Fungi: Detente and Disease.Annual review of pathology · 2017
    Review
  15. Article
  16. Article
  17. Anti-Immune Strategies of Pathogenic Fungi.Frontiers in cellular and infection microbiology · 2016
    Review
  18. Review
  19. Article
  20. Complement Attack against Aspergillus and Corresponding Evasion Mechanisms.Interdisciplinary perspectives on infectious diseases · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

T R KozelDepartment of Microbiology and Cell and Molecular Biology Program, University of Nevada, Reno 89557, USA.
University of Nevada, Reno · US

Funding

PHOSPHOMANNOPROTEIN ADHESIN AS A VACCINE CANDIDATEP01AI037194 · NIAID · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI EDWARDS, JOHN E. · 1995 to 2003
$3.6M
Cryptococcal polysaccharide-phagocytosis inhibitionR01AI014209 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 1985 to 2009
$1.9M
CRYPTOCOCCAL POLYSACCHARIDE--PHAGOCYTOSIS INHIBITIONR37AI014209 · NIAID · UNIVERSITY OF NEVADA RENO · PI KOZEL, THOMAS R · 1995 to 2004
$1.5M
PHEROMONE CONTROL OF CRYPTOCOCCUS NEOFORMANS GROWTHU01AI031696 · NIAID · UNIVERSITY OF CALIFORNIA IRVINE · PI SELSTED, MICHAEL E · 1991 to 1994
–
NIAID NIH HHS AI 14209NIAID NIH HHS AI 31696NIAID NIH HHS AI 37194
6 · The paper itself

Abstract

Fungi have been studied as prototype activators of the complement cascade since the early 1900s. More recently, attention has focused on the role of the complement system in the pathogenesis of fungal infections. The interactions of Cryptococcus neoformans and Candida albicans with the complement system are the most widely characterized; however, all pathogenic fungi examined to date have the ability to initiate the complement cascade. The molecular mechanisms for initiation and regulation of the complement cascade differ from one fungus to another, most likely reflecting differences in the structure of the outer layers of the cell wall. The molecular bases for such differences remain to be identified. Studies of mycoses in experimental animals with induced or congenital deficiencies in the complement system demonstrate that complement is an important innate system for control of fungal infection. Contributions to host resistance include opsonization and generation of inflammatory mediators. Inflammation induced by chemotactic products of the complement system may contribute to the pathogenesis of some fungal infections.

Indexed as

Complement ActivationAspergillosisCandidiasisComplement C3Complement Pathway, AlternativeComplement Pathway, ClassicalCryptococcosisFungiKineticsMycosesComplement C3

Identifiers

PMID8665475
PMCPMC172880
OpenAlexW2125033177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.